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The nuclear exosome and its essential co-factor, the RNA helicase MTR4, play crucial roles in
several RNA degradation pathways. Besides unwinding RNA substrates for exosome-
mediated degradation, MTR4 associates with RNA-binding proteins that function as adaptors
in different RNA processing and decay pathways. Here, we identify and characterize the
interactions of human MTR4 with a ribosome processing adaptor, NVL, and with ZCCHC8,
an adaptor involved in the decay of small nuclear RNAs. We show that the unstructured
regions of NVL and ZCCHC8 contain short linear motifs that bind the MTR4 arch domain in a
mutually exclusive manner. These short sequences diverged from the arch-interacting motif
(AIM) of yeast rRNA processing factors. Our results suggest that nuclear exosome adaptors
have evolved canonical and non-canonical AIM sequences to target human MTR4 and
demonstrate the versatility and speciﬁcity with which the MTR4 arch domain can recruit a
repertoire of different RNA-binding proteins.
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Eukaryotic cells generate a multitude of RNA species thatrequire timely maturation and decay to maintain a healthytranscriptome. A central machinery in nuclear RNA pro-
cessing, quality control and decay pathways is a conserved 3′–5′
exoribonuclease complex known as the RNA exosome (reviewed
in1,2). Most mechanistic studies to date have analyzed the RNA
exosome from S. cerevisiae, the species in which it was originally
identiﬁed 20 years ago3. The yeast exosome consists of a 10-
subunit core complex (Exo10)4, the activity of which depends on a
single processive exoribonuclease (Rrp44, also known as Dis3)5,6.
The Exo10 core is present in both nuclear and cytoplasmic
compartments, but its cofactors and regulators have distinct
subcellular localizations (reviewed in1,2). In the nucleus, Exo10 is
bound to the distributive ribonuclease Rrp6 and its associated
protein Rrp47 as well as to the Mpp6 protein7–9. Together, Rrp6-
Rrp47 and Mpp6 recruit the RNA helicase Mtr4 to the exo-
some10–12. Orthologues of all these 14 proteins exist in human
cells, and engage in similar interactions to form the corre-
sponding human nuclear exosome complex12,13.
In both yeast and humans, the nuclear helicase Mtr4/MTR4 is
central to exosome function2,14,15. First, it functions as an enzyme
to remodel ribonucleoprotein (RNP) substrates with its 3′–5′
unwinding activity, and to present the unwound RNA substrate
to the exosome core12,16. Furthermore, it functions as a binding
platform for RNA-binding adaptors, providing the primary
interactions to transcripts subjected to exosomal degradation in
both RNA processing and decay pathways17,18. For example, S.
cerevisiae Mtr4 binds Nop53, a ribosome biogenesis factor that
recruits the exosome for a late step in rRNA processing, namely
the trimming of ITS2 (Internal Transcribed Spacer 2). Two other
factors, Trf4 and Air2, bind Mtr4 to form the so-called TRAMP
complex19–21, which allows the exosome to target aberrant
tRNAs22, rRNAs and small nuclear and nucleolar RNAs (sn/
snoRNAs) for decay23. Higher eukaryotes not only have ortho-
logues of Nop53 and TRAMP, but also have an increased number
of nuclear exosome adaptors. In human cells, MTR4 has been
reported to interact with the early ribosome biogenesis factors
WDR74 and NVL, which take part in the processing of ITS1
(Internal Transcribed Spacer 1)24,25. Human MTR4 also binds to
two large Zinc-ﬁnger proteins, ZCCHC8 and ZFC3H1. ZCCHC8
interacts with MTR4 and the RNA-binding protein RBM7 to
form the trimeric Nuclear EXosome Targeting (NEXT)
complex17,26, which targets enhancer RNAs (eRNAs), promoter
upstream transcripts (PROMPTs) and intronic RNAs for
exosome-mediated decay27. ZFC3H1 instead directs MTR4 and
the nuclear exosome to polyadenylated nuclear RNAs by con-
necting to the nuclear poly(A) binding protein PABN128–30.
Furthermore, MTR4 binds NRDE-2, a negative regulator that
prevents the nuclear exosome from targeting RNAs that should
be exported to the cytoplasm31.
How does the nuclear exosome helicase mediate binding to
such a diverse and functionally distinct set of proteins? Structural
studies have shown that yeast Mtr4 contains an unstructured N-
terminal region, a DExH helicase core and an ‘arch’ domain with
a globular Kyprides, Ouzounis, Woese (KOW) domain14,32. All
Mtr4 domains are involved in protein-protein interactions: the N-
terminal region binds Rrp6-Rrp4711, the helicase core binds
Mpp6 as well as Trf4-Air233,34 and the KOW domain binds a
short sequence known as ‘arch-interacting motif’ that is present
in Nop53, Utp18, and Air235,36. In the case of human MTR4,
both the arch domain and the DExH helicase core bind NRDE-
231. Structural data have also elucidated how the helicase core of
human MTR4 binds a region of ZCCHC837. This protein is
however expected to harbor another MTR4-binding region37,
which remains to be identiﬁed. Also unclear is how other human
MTR4-binding proteins are recognized. With the exception of the
expected AIM sequence in the human NOP53 orthologue (also
known as GLTSCR2) and in NRDE-231, there is no consensus
motif that can be identiﬁed with conﬁdence at the sequence level
in other MTR4-binding factors. Here, we used a combination of
biochemical studies, X-ray crystallography and nuclear magnetic
resonance (NMR) experiments to obtain mechanistic insights
into how human MTR4 interacts with two metazoan RNA exo-
some adaptors: the RNA processing factor NVL and the RNA
decay factor ZCCHC8.
Results
The unstructured region of human NVL interacts with MTR4.
The nuclear VCP-like (NVL) protein, also known as NVL2, is a
ribosome biogenesis factor of the AAA-ATPase family that has
been reported to interact with human MTR438. NVL is a multi-
domain protein characterized by an N-terminal nucleolin-bind-
ing domain (residues 10–74)39 and a linker region (residues
76–266) followed by two globular domains, characteristic of
AAA-ATPases that are responsible for catalytic activity (Fig. 1a,
Supplementary Fig. 1a). Bioinformatic analyses suggested that the
linker region is mostly unstructured (residues 76–239) (Supple-
mentary Fig. 1b). In other AAA-ATPases, unstructured regions
upstream of the catalytic domains often mediate protein-protein
interactions40–42. To test if the portion upstream of the NVL
catalytic domains mediates the interaction with MTR4, we
expressed and puriﬁed the N-terminal region of human NVL
tagged with thioredoxin (Trx) as the prey protein (Trx-NVL1–266)
and the structured portion of MTR4 tagged with glutathione-S-
transferase (GST) as the bait protein (GST-MTR4-ΔN). In these
assays, Trx-NVL1–266 speciﬁcally co-precipitated with GST-
MTR4-ΔN (Fig. 1b, lane 11, compare with GST control in lane 9).
Interestingly, pull-down assays with the recombinant yeast
orthologues showed that the N-terminal unstructured region of
Rix7 does not interact with yeast Mtr4 (Supplementary Fig. 1c),
indicating that the interaction between human NVL and MTR4 is
not conserved in S. cerevisiae.
We narrowed down the MTR4-interacting region of human
NVL based on bioinformatic analysis. Sequence alignments
showed that the N-terminal unstructured region of NVL contains
an insertion that is present in the human protein and other
chordates but not in the yeast orthologue (Supplementary Fig. 1a).
Upon testing whether this insertion is responsible for the
interaction with human MTR4, we found that a construct
encompassing the conserved portion of the human NVL insertion
spanning residues 167–216 (Supplementary Fig. 1a) was indeed
able to co-precipitate with GST-MTR4-ΔN in pull-down assays
(Fig. 1b, lane 14, Trx-NVL167–216). Thus, the MTR4-binding
determinants of NVL reside in an unstructured region that is
present in the human orthologue and more generally in chordate
NVL proteins, but not in lower eukaryotes.
NVL targets the MTR4 KOW domain. To identify where the
MTR4-binding determinants for NVL reside, we performed GST
pull down assays with MTR4 constructs harboring the DExH core
of the helicase (GST-MTR4ΔNΔarch) and the KOW domain
(GST-MTR4 KOW). Neither Trx-NVL1–266 nor Trx-NVL167–216
co-precipitated with GST-MTR4-ΔNΔarch (Fig. 1b, lanes 12 and
15). In contrast, the KOW domain characteristic of the MTR4
arch (GST-MTR4-KOW) was able to co-precipitate both Trx-
NVL1–266 and Trx-NVL167–216 (Fig. 1b, lanes 13 and 16). We
quantiﬁed the strength of the interaction by biophysical approa-
ches. Using microscale thermophoresis (MST), we measured a
dissociation constant of ~1 µM between a YFP-tagged version of
NVL167–216 and MTR4-KOW (Fig. 1c). A similar dissociation
constant was obtained when testing the interaction of NVL167–216
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and MTR4-ΔN using isothermal titration calorimetry (ITC)
(Supplementary Fig. 1d). The fact that the KOW domain alone
binds NVL167–216 as strongly as MTR4-ΔN indicated that the
NVL167–216 binding region resides within the KOW domain.
We proceeded to characterize the NVL167–216-binding site of
MTR4 with structural approaches. Using NMR spectroscopy, we
conﬁrmed that the MTR4-KOW domain has a sequential
arrangement of secondary structure elements consistent with
the fold observed in a recent crystal structure of an MTR4-
NRDE-2 complex31, namely a ﬁve-stranded β-sheet ﬂanked by a
long C-terminal helix and containing smaller helical segments
within loops (Supplementary Fig. 2). We then carried out
titration experiments using a 15N-labelled MTR4-KOW protein
and adding increasing amounts of unlabeled NVL167–216. In line
with a dissociation constant of ~1 µM, we observed an
intermediate exchange regime for most of the peaks during the
titration in HSQC (heteronuclear single quantum coherence)
spectra. Chemical shift perturbations (CSP) measured upon
NVL2167–216 addition revealed signiﬁcant effects (Fig. 2a–c) with
clusters of strongly shifting peaks around residues 658, 695, 743,
and 764. From the NMR analysis of the NVL167–216 - MTR4-
KOW interaction, the CSPs were very similar to those we had
previously reported for the yeast Nop53-Mtr4 KOW interaction36
(Supplementary Fig. 3a, 3b). Consistently, a reverse-charge
substitution of Arg743 (R743E mutant) impaired the binding of
both NVL167–216 (pull-down assays in Fig. 2d, lane 8) and of the
human Nop53 orthologue (Supplementary Fig. 3c).
Identiﬁcation of W-AIM: a tryptophan arch-interacting motif
of NVL. Given that NVL167–216 binds the KOW domain of
MTR4 similarly to Nop53, we expected the presence of a similar
AIM motif. A stretch of amino acids within this segment (NVL
residues 185–190) appeared to show signiﬁcant sequence simi-
larity to the Nop53 AIM sequence (Fig. 3a). Surprisingly in this
context, the F186A and D189R mutations in the Nop53-like
stretch did not affect NVL167–216 binding to MTR4 in a pull-
down assay with recombinant proteins (Fig. 3b, compare lanes 5
and 6), indicating that this segment is not a bona-ﬁde AIM. To
identify the arch-interacting motif in NVL167–216, we analyzed
the sequences from different species in terms of evolutionary
conservation. We noticed that vertebrates feature a conserved
hydrophobic segment GWFIDKTP (residues 172–179, Fig. 3a;
Supplementary Fig. 1a). Mutations in this segment (W173A,
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Fig. 1 The N-terminal unstructured region of NVL interacts with the MTR4 KOW. a Schematic representation of the domain organization of NVL and
MTR4. Domain boundaries are obtained from previous studies31,37 and the crystal structure in the current report. The arrows indicate nomenclature for
MTR4 constructs used in the text. b Protein co-precipitation assays. GST-tagged MTR4ΔN, MTR4ΔNΔarch, and MTR4 KOW were incubated with either
Trx-NVL1–266 or Trx-NVL167–216 before co-precipitation with glutathione sepharose beads. A total of 3% of the input (lanes 1–8) and 30% of the eluates
(lanes 9–16) were analyzed on 15% SDS-PAGE gels stained with coomassie brilliant blue. c Microscale thermophoresis experiment with MTR4 KOW and
Trx-NVL167–216-(GS)3-eYFP. In all, 50 nM of Trx-NVL167–216-(GS)3-eYFP was incubated with increasing concentrations of MTR4 KOW and thermophoresis
was measured by tracking the ﬂuorescence of the NVL-YFP fusion protein. The binding isotherm was calculated using MO software (Nanotemper
technologies) and the dissociation constant (Kd) is given in the inset. The error bars represent the standard deviations of each data point calculated from
three independent thermophoresis measurements
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I175E) either abolished or impaired NVL167–216 binding to
MTR4ΔN in pull-down assays in vitro (Fig. 3b, lanes 7 and 8),
suggesting that this stretch functions as an arch-interacting motif,
which we coin ‘tryptophan-centered arch - interacting motif’ (W-
AIM).
We co-crystallized the NVL W-AIM peptide in complex with a
construct of human MTR4 encompassing both the DExH core
and the arch domain (residues 70–1042) (Table 1). The overall
structure of the helicase is similar to that of the human NRDE-2-
MTR4 complex31, but with a notably different conformation of
the arch domain. In the NVL-bound crystal structure, the arch
domain of MTR4 is an open conformation, with the KOW
domain clearly separated from the helicase core (Fig. 3c and
Supplementary Fig. 4a). The NVL W-AIM polypeptide chain
binds in an extended conformation, similar to that reported for
NRDE-231, Nop5336 and Air234 (Supplementary Fig. 4b, 4c). The
hydrophobic side chains of Trp173NVL, Phe174NVL, and
Ile175NVL contact Val766MTR4, Tyr745MTR4, and Val742MTR4
respectively, while Asp176NVL interacts with Arg743MTR4
(Fig. 3d). The NVL polypeptide chain then forms a pronounced
bend at Pro179NVL (which contacts Phe653MTR4) and continues
to form a crystal contact, docking at the Trf4-binding site of a
symmetry related helicase core (Supplementary Fig. 5a).
Consistent with the structural data, mutation of Asp176NVL
(D176A mutant) impairs the binding of NVL167–216 to MTR4ΔN
in a GST pull down experiment (Supplementary Fig. 5b).
Finally, we tested the effect of the MTR4-interacting residues of
NVL in human cells. To this end, we carried out co-
immunoprecipitation (co-IP) assays in HeLA cells stably expres-
sing MTR4 with an eGFP ‘localization and afﬁnity puriﬁcation’
(LAP) tag at the N-terminus and transiently expressing FLAG-
tagged full-length NVL constructs (wild type, or with the W173A/
I175A mutation or with deletion of the entire hydrophobic
segment). Western blotting analysis conﬁrmed that wild type
NVL bound MTR4 and that disruption of the 172–180 segment,
either by mutation or deletion, impaired the NVL-MTR4
interaction (Fig. 3e, compare lanes 8, 9, 10). Taken together, we
conclude that NVL interacts with the KOW domain of MTR4
using a short linear W-AIM sequence. The NVL W-AIM is more
hydrophobic than the Nop53 AIM35, rationalizing why it binds
MTR4 with an order of magnitude higher afﬁnity than the yeast
Nop53-Mtr436 and human Nop53-MTR4 interactions (Supple-
mentary Fig. 3d).
The unstructured region of ZCCHC8 interacts with the MTR4
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Fig. 2 Analysis of MTR4 KOW-NVL complex by NMR and site directed mutagenesis. a Overlay of 1H-15N-HSQCs of either MTR4 KOW alone (black) or in
complex with a six-fold excess of NVL2 (red). Selected residues experiencing large chemical shift perturbations (CSPs) are labeled. b Plot of CSPs per
residue of the MTR4 KOW sequence. The red line marks the threshold of signiﬁcant CSPs, which are mapped on the model of MTR4 KOW (PDB 6IEH) in
panel c. Gaps indicate either prolines or residues that could not be assigned. cMTR4 KOW domain (PDB 6IEH) with labeled secondary structural elements
as assigned by NMR and residues showing signiﬁcant CSPs (displayed as red/green spheres). d Protein co-precipitations by pull down assays. GST-tagged
MTR4ΔN (WT or mutants) were incubated with Trx-NVL167–216 before co-precipitation with glutathione sepharose beads. A total of 3% of the input (lanes
1–4) and 30% of the eluates (lanes 5–8) were analyzed on 15% SDS-PAGE gels and visualized by staining with coomassie brilliant blue
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motivated us to examine whether other known MTR4 interactors
also contain a similar tryptophan-centered motif. One such
interactor is ZCCHC8, the scaffolding subunit of the NEXT
complex27,37,43. This modular protein contains a predicted N-
terminal coiled–coil domain (residues 40–80), a Zinc-knuckle
domain (residues 222–246), a proline-rich domain (residues
287–334) that interacts with RBM743 and a C-terminal domain
(CTD) (residues 659–707) (Fig. 4a) that interacts with the DExH
core of MTR4 and activates it37. The N-terminal portion of
ZCCHC8 is expected to contain an additional MTR4-binding
site37. Within the N-terminal portion, we focused our attention
on the linker between the coiled-coil and the Zinc-knuckle
domains, as it appeared to contain an NVL-like tryptophan-
containing sequence (Supplementary Fig. 6a). We expressed a
large portion of this linker (residues 91–211) tagged to maltose
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construct for pull-down assays with the versions of GST-tagged
MTR4 described above (Fig. 1a). MBP-ZCCHC891–211 co-
precipitated with GST-MTR4-ΔN but not with GST-MTR4-
ΔNΔarch (Fig. 4b, lanes 6 and 7). Similar to the results we had
obtained for NVL167–216, the pull-down assays showed that MBP-
ZCCHC891–211 interacts with GST-MTR4-KOW (Fig. 4b, lane 8).
Next, we determined the afﬁnity of the MTR4-KOW-
ZCCHC891–211 interaction using microscale thermophoresis
(MST) with a ﬂuorescent-tagged version of ZCCHC891–211 (that
we had engineered by fusing a YFP to the C-terminus). In this
quantitative assay, we measured a dissociation constant (KD) of
~0.3 µM (Fig. 4c), indicating a higher afﬁnity than that of the
NVL167–216 fragment. To corroborate these results, we pre-formed
a GST-MTR4-ΔN - Trx-NVL167–216 complex and incubated it
with increasing amounts of MBP-ZCCHC891–211 before subject-
ing the mixtures to GST pull-down assays. The competition assay
showed that ZCCHC891–211 could displace NVL167–216 from the
pre-formed complex (Fig. 4d, lanes 5–8), suggesting that they
interact with the exosome helicase in a mutually exclusive manner.
Identiﬁcation of C-AIM: a cysteine arch-interacting motif of
ZCCHC8. We proceeded to identify the MTR4-binding site
within the N-terminal region of ZCCHC8. We ﬁrst interrogated
the NVL-like tryptophan-containing patch (GWEIPK, residues
197–202, Fig. 5a). Surprisingly, mutation of Trp198 and Lys202
(W198A/K202E mutant) did not alter the interaction of
ZCCHC891–211 with MTR4-ΔN in GST pull down assays (Fig. 5b,
lane 7), indicating that this patch of ZCCHC8 is not a bona-ﬁde
W-AIM sequence.
To identify the arch-interacting motif in ZCCHC891–211, we
took a similar bioinformatics approach as described above
for NVL. When analyzing the evolutionary conservation of
ZCCHC891–211, we identiﬁed a conserved patch centered at the
FCLDKLG segment (residues 178–184, Fig. 5a). Mutation of
Phe178 and Asp181 (F178A/D181R mutant) in this segment
impaired the interaction with MTR4-ΔN (Fig. 5b, lane 6). This
cysteine-centered arch-interacting motif (C-AIM) is loosely
related to the Nop53 AIM and the NVL W-AIM segments, and
is thus expected to bind to the same site of the KOW domain.
Consistently, the Arg743 reverse-charge substitution (R743E) in
MTR4 also impaired the binding of ZCCHC891–211 (Fig. 5c,
lane 8).
ZCCHC8 also contains a non-canonical arch-interacting motif:
I-AIM. While attempting to narrow down the KOW binding
region of ZCCHC8 further, we observed that N-terminal trun-
cation of ZCCHC891–211 resulted in a near loss of MTR4 binding
(Supplementary Fig. 6b). Based on these results, we reasoned that
ZCCHC891–211 might harbor an additional MTR4-binding motif
that would be predicted to bind to an adjacent surface on the
KOW domain (and thus show no resemblance to the previously
identiﬁed arch-interacting motifs). Using bioinformatics
approaches, we identiﬁed another conserved segment upstream of
C-AIM (IEEF, residues 112–115). Indeed, mutation of Ile112 and
Phe115 (I112R/F115R mutant) severely weakened the MTR4-ΔN
- ZCCHC891–211 interaction in GST pull-down assays (Fig. 5b,
lane 8). Thus, this segment (which we refer to as an isoleucine-
centered arch-interacting motif, or I-AIM) also contributes to
MTR4 binding. Next, we mapped the possible MTR4-binding site
of I-AIM. The β-barrel of the MTR4 KOW domain is structurally
related to that of Tudor domains (Supplementary Fig. 7a), small
globular folds that generally present a hydrophobic pocket for
binding methylated arginines and lysines44. Although there is
little overall sequence similarity, MTR4-KOW features hydro-
phobic residues at the equivalent position of the
substrate–binding residues of Tudor domains (Supplementary
Fig. 7b)44,45. In particular, MTR4 Phe677 is evolutionarily con-
served (Supplementary Fig. 7b) and is located on a surface
adjacent to the Arg743 site where the Nop53 like AIM, W-AIM
and C-AIM sequences are recognized (Supplementary Fig. 7c). In
line with this site being used for the additional I-AIM sequence of
ZCCHC891–211, mutation of Phe677 (F677E) disrupted binding
of ZCCHC891–211 (Fig. 5c, lane 7) and did not affect the binding
Fig. 3 The vertebrate speciﬁc W-AIM in NVL is crucial for binding to MTR4 KOW. a Sequence alignment of vertebrate speciﬁc insertion regions of
representative NVL sequences, Homo sapiens (Hs), Gallus gallus (Gg), Xenopus tropicalis (Xt), highlighting the W-AIM (GWFIDKTP) (red box), and the
Nop53-like region (LFXϕD) (purple). The sequences were obtained from the UniProt database and aligned using the T-coffee server59. b Protein co-
precipitations by pull down assays. GST-tagged MTR4ΔN was incubated with either wild type Trx-NVL167–216 or its indicated mutant before co-
precipitation with glutathione sepharose beads. A total of 3% of the input (top) and 30% of the eluates (bottom) were analyzed on 15% SDS-PAGE gels
and visualized by staining with coomassie brilliant blue. c Overall structure of MTR4ΔN270–1042 - NVL167–216 complex, with the DExH core of MTR4
colored in gray and arch colored in light blue. NVL is colored in orange. d Zoom-in view of the interactions between MTR4 KOW (light blue) domain and
NVL (orange). Domains are colored as in Fig. 3a and viewed are 90° rotation along the horizontal and vertical axes with respect to the view in Fig. 3a.
Residues discussed in the text are highlighted and labeled. e Cellular co-IP assay. FLAG-tagged wild type NVL construct, or its indicated mutant variant,
were transiently expressed in cells stably expressing MTR4-LAP. After precipitation of MTR4-LAP, a total of 0.5% of the input (left) and 8.0% of the
eluates (right) were analyzed on 4–12% SDS-PAGE gel followed by western blotting analysis. The primary antibody used is indicated below the panel
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of NVL167–216 (Fig. 2d, lane 7) or human Nop53 (Supplementary
Fig. 3c, lane 7).
We tested the importance of the I-AIM segment in human
cells. HeLa LAP-MTR4 cells were transfected with FLAG-tagged
full-length ZCCHC8 constructs (wild type, the I-AIM I112R/
F115R double mutant or a deletion construct lacking the
ZCCHC8 CTD). Western blotting analysis of the resulting co-
IPs revealed that disrupting the I-motif by mutation is sufﬁcient
to impair the ZCCHC8-MTR4 interaction, whereas deletion of
the CTD did not signiﬁcantly affect complex formation (Fig. 5d,
lanes 8, 9, 10). These mutations also did not affect the ZCCHC8-
RBM7 interaction (Supplementary Fig. 6c). The CTD of ZCCHC8
has been shown to bind the DExH core of MTR4 and to enhance
helicase activity37. In contrast, we found that neither the
ZCCHC8 nor the NVL AIM motifs have a signiﬁcant effect on
the catalytic properties of MTR4, as judged by assaying both ATP
hydrolysis and RNA helicase activities (Supplementary Fig. 8).
These results suggest a division of labor of the N-terminal and C-
terminal ZCCHC8 regions: while the C-terminal domain
regulates the activity of the helicase37, the N-terminal region
plays has a central scaffolding role in incorporating MTR4 into
the NEXT complex.
Discussion
In this study, we show that the human nuclear exosome adaptors
NVL and ZCCHC8 bind the MTR4 KOW domain on a surface
that is also employed by Nop5336 and NRDE-231 using distinct
arch-interacting motifs35. The AIMs of Nop53/Utp18/Air2
(LFxϕD(x)1–2G/P), NVL (GWFIDKTP), ZCCHC8
(NFCLDKLG), and NRDE-2 (SFRTDKKP) can best be con-
sidered as subfamilies of canonical AIMs. With insight, sequences
in both NVL and ZCCHC8 that at ﬁrst glance appeared to
resemble known AIMs instead contain individual amino acids
that are likely to prevent MTR4 binding. The consensus sequence
of canonical bona-ﬁde AIMs can thus be re-deﬁned as xωxxD(x)1/
2G/P, with a C-terminal glycine or proline residue that allows the
polypeptide chain to bend as it extends away from its binding site.
The aromatic (ω) and polar/non-polar amino acids might vary,
but tend to be conserved within individual subfamilies of cano-
nical AIMs. Despite the variability, all canonical AIM sequences
are recognized, in a mutually exclusive manner, at a surface
pocket of the MTR4 KOW domain that is deﬁned by the presence
of Arg743 (yeast Mtr4 Arg774). Mutation of this surface pocket
may thus be a useful tool to probe new MTR4-interacting
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Fig. 4 The N-terminus of ZCCHC8 interacts with the MTR4 KOW domain.
a Schematic representation of the domain organization of ZCCHC8.
Domain boundaries are obtained from previous studies37,43 and
computational sequence analysis. b Protein co-precipitations by pull down
assays. GST-tagged MTR4ΔN, MTR4ΔNΔarch, and MTR4 KOW were
incubated with MBP-ZCCHC8 91–211 before co-precipitation with
glutathione sepharose beads. A total of 3% of the input (lanes 1–4) and
30% of the eluates (lanes 5–8) were analyzed on 12% SDS-PAGE gels and
visualized by staining with coomassie brilliant blue. c Microscale
thermophoresis experiment with MTR4 KOW and MBP-ZCCHC8 91–211-
(GS)3-eYFP. In all, 1 μM MBP-ZCCHC8 91–211-(GS)3-eYFP was incubated
with increasing concentrations of MTR4 KOW and thermophoresis was
measured by tracking the ﬂuorescence of the ZCCHC8-YFP fusion protein.
The binding curve was calculated using MO software (Nanotemper
technologies) and the dissociation constant (Kd) is given in the inset. The
error bars represent the standard deviations of each data point calculated
from three independent thermophoresis measurements. d Competition
experiment using GST pull down assay technology. A preformed GST-
MTR4ΔN:Trx-NVL167–216 complex was incubated with increasing
concentrations of MBP-ZCCHC8(91–211) before precipitation with
glutathione sepharose beads. A total of 3% of the input (lanes, 1–4) and
30% of the eluates (5–8) were analyzed on 15% SDS-PAGE gels and
visualized by staining with coomassie brilliant blue
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proteins that contain arch-interacting motifs, as these motifs are
difﬁcult to identify due to the degeneracy of their consensus
sequence. Furthermore, we found that ZCCHC8 harbors an
additional arch-interacting motif that does not conform to the
canonical AIM consensus sequences. These ﬁndings show how
different exosome adaptor proteins have evolved similar
mechanisms to recognize MTR4 in a speciﬁc and mutually
exclusive manner, but can also modulate the afﬁnity and thus
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Fig. 5 Analysis of the ZCCHC8-MTR4 KOW complex by site directed mutagenesis. a Sequence alignment of the region between the predicted coiled coil
domain and the zinc ﬁnger of ZCCHC8 from representative metazoan species, Homo sapiens (Hs), Gallus gallus (Gg), Xenopus laevis (Xl), highlighting NVL-
like region (red), Nop53-like AIM (C-AIM) and ZCCHC8 speciﬁc I-AIM (purple boxes). The sequences were obtained from the UniProt database and
aligned using the T-coffee server59. b Protein co-precipitations by pull down assays testing ZCCHC8 91–211 mutants for MTR4ΔN binding ability. GST-
tagged MTR4ΔN was incubated with either ZCCHC891–211 WT or mutants before co-precipitation with glutathione sepharose beads. A total of 3% of the
input (top) and 30% of the eluates (bottom) were analyzed on 12% SDS-PAGE gels and visualized by staining with coomassie brilliant blue. c Protein co-
precipitations by pull down assays testing MTR4ΔN mutants for their ZCCHC8 91–211 binding ability. GST-tagged MTR4ΔN (WT or mutant variants) were
incubated with MBP-ZCCHC8 91–211 before co-precipitation with glutathione sepharose beads. A total of 3% of the input (lanes, 1–4) and 30% of the
eluates (5–8) were analyzed on 12% SDS-PAGE gels and visualized by staining with coomassie brilliant blue. d Cellular co-IP assay. FLAG-tagged ZCCHC8
constructs (WT/IF mutant/CTD deletion) were transiently expressed in cells stably expressing MTR4-LAP. After precipitation of MTR4 taking advantage
of the LAP tag, a total of 0.5% of the input (left) and 8.0% of the eluates (right) were analyzed on 4–12% SDS-PAGE gel followed by western
blotting analysis. The primary antibody used is indicated below the panel
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Methods
Protein expression and puriﬁcation. Human MTR4 constructs (full-length,
MTR4-ΔN (75–1042), MTR4-KOW (645–787) and MTR4-ΔNΔarch, where resi-
dues 598–842 were substituted by 2xGS linker) were expressed as 6xHis-GST-
tagged fusion (cleavable with 3 C protease) proteins in BL21 star (DE3) E. coli cells,
grown either in terriﬁc broth (for biochemical studies) or minimal medium sup-
plemented with 15N labelled ammonium chloride and/or 13C labeled Glucose (for
NMR studies). The proteins were puriﬁed using a Ni-nitrilotriacetate (NTA) afﬁ-
nity column and a heparin column (GE healthcare) for ion exchange chromato-
graphy. When appropriate, the His-GST tag was cleaved at this point by incubation
with 3 C protease, followed by removal of the tag with an additional Ni-NTA
afﬁnity step. Finally, the protein was subjected to size exclusion chromatography
on a Superdex 200 column (GE healthcare) in 50 mM Hepes/NaOH pH 7.5,
150 mM NaCl, 5% (v/v) glycerol, 2 mM DTT.
The human MTR4 construct used for crystallization (71–1042) was cloned as
GST fusion construct with a TEV cleavage site immediately preceding the
MTR4 sequence which when cleaved would leave a glycine (the natural 70th
residue in MTR4) yielding MTR4 protein with residues 70–1042 (referred to as
MTR4ΔN2 in the text). The construct was puriﬁed as described above.
The primers used for cloning all the constructs described are listed in
Supplementary table 1.
All NVL and ZCCHC8 constructs and truncation mutants described in the text
were expressed as 6xHis-Trx and 6xHis-MBP tagged fusion (cleavable with 3 C
protease) proteins, respectively in BL21 star (DE3) E. coli cells. The proteins were
puriﬁed using a Ni-NTA afﬁnity column. When appropriate, the tags were cleaved
upon incubation with 3 C protease at this step, followed by an additional Ni-NTA
afﬁnity step for the removal of the tag. In case of ZCCHC8, the tag cleavage was
performed only in the presence of MTR4 to prevent the protein from precipitating.
In the ﬁnal puriﬁcation step, the proteins were subjected to size-exclusion
chromatography on a Superdex 75 in 50 mM Hepes/NaOH pH 7.5, 150 mM NaCl,
2 mM DTT.
Biophysical assays. The microscale thermophoresis measurements were per-
formed on a NanoTemper Monolith NT.115 machine. Before the measurements,
all samples were dialyzed against a buffer containing in 50 mM Hepes/NaOH pH
7.5, 150 mM NaCl, 5% (v/v) glycerol, 0.5 mM TCEP. For NVL, 50 nM of Trx-
NVL167–217-(GS)3-eYFP was incubated with increasing concentrations of unlabeled
MTR4 KOW and thermophoresis was measured with an MST power of 20% and
an LED power of 20%. For ZCCHC8, 1 μM of MBP-ZCCHC891–211 -(GS)3-eYFP
was incubated with increasing concentrations of unlabeled MTR4-KOW and
thermophoresis was measured with an MST power of 70% and an LED power of
15%. In both cases, the MTR4 KOW concentration series was produced by serial
dilution (1:1). Titrations were performed in triplicates and the data were analyzed
using the Thermophoresis with T-Jump strategy option with the MO software
(NanoTemper Technologies).
Isothermal calorimetry experiments were carried out using the ITC200
Isothermal titration calorimeter from Microcal. Before the measurement, all
samples were dialysed against a buffer containing 50 mM Hepes/NaOH pH 7.5,
150 mM NaCl, and 0.5 mM TCEP. For NVL: MTR4-ΔN (the reactant) samples
were concentrated to 40 µM and NVL (the injectant) to 500 µM. For human
NOP53: MTR4-KOW (the reactant) samples were concentrated to 100 µM and
NOP53 (the injectant) to 1 mM. Titrations were carried out at 25 °C with 2 µL of
the injectant per injection added to 200 µL of reactant cell solution. All data were
processed and curves ﬁtted using Origin5.0.
Biochemical assays. For pull-down assays, appropriate protein mixtures were
incubated in 50 mM Hepes (pH 7.5), 150 mM NaCl, 5% (v/v) glycerol, 0.05% (v/v)
NP40, 1 mM DTT for 30 min at 4 °C. For ZCCHC8, 2 μM GST-MTR4ΔN was
incubated with 8 μM MBP-ZCCHC8 constructs. For NVL, 10 μM GST-MTR4ΔN
was incubated with 20 μM Trx-NVL constructs. For NOP53, 30 μM GST-
MTR4ΔN was incubated with 60 μM Trx-NOP5384–123 in a total volume of 30 μl.
The protein mixtures were then incubated with Glutathione sepharose beads (GE
healthcare) for 2 h. Post incubation, the beads were washed three times with 0.1 ml
incubation buffer and the retained material was eluted with incubation buffer
supplemented with 30 mM reduced glutathione. Input material (1–3%) and eluates
(~30%) were analyzed by SDS-PAGE and Coomassie staining.
For ATPase assays, 150 pmol of MTR4ΔN or MTR4ΔN-containing complexes
were incubated 40 nmol MESG (2-amino-6-mercapto-7-methylpurine
ribonucleoside) and 0.5 U purine nucleoside phosphorylase (Enzchek Phosphate
Assay kit, Invitrogen) in a buffer containing 50 mM MOPS pH 6.5, 50 mM Nacl,
2.5 mM MgCl2, 5 mM β-mercaptoethanol and 5% (v/v) glycerol. For reactions
containing RNA, the mixture was incubated with 2 μg poly-U RNA (Sigma). The
reaction was initiated by addition of ATP to a ﬁnal concentration of 1 mM. The
generation of 2-amino-6-mercapto-7-methylpurine from MESG was monitored by
measuring absorbance increase at 360 nm on a plate reader (Inﬁnite M1000 Pro,
Tecan) for 12 min at 60 s intervals. The data were normalized by subtracting the y-
intercept from the raw data. The experiment was performed in triplicate. The mean
(n= 3) and standard deviation (error bars) were plotted using Graphpad prism 8.
Helicase assays were performed essentially as described by Puno et al.37. A
duplex RNA was formed by mixing a 5’ Fluorescein amidite (FAM) labeled RNA
(FAM-AGCACCGUAAAGACGC) with 1.5 molar excess of complementary RNA
with a 25 A overhang (GCGUCUUUACGGUGCUAAAAAAAAAAAAAAAAA
AAAAAAAA) in a buffer containing 20 mM Tris-HCl pH 7.5 and 50 mM NaCl.
To anneal the RNA duplex, the mixture was heated to 95 °C and allowed to cool
down slowly to ambient temperature by turning off the heat block. 0.3 pmol of
duplex RNA was incubated with 3.75, 7.5, 30 pmol of MTR4ΔN or MTR4ΔN-
containing complexes in a buffer containing 50 mM MOPS pH 6.5, 50 mM Nacl,
0.5 mM MgCl2, 5 mM β-mercaptoethanol and 5% (v/v) glycerol for 5 min at 30 °C.
The reaction was then initiated by the addition of ATP, MgCl2 and a trap DNA
oligo complementary to the FAM labeled RNA (GCGTCTTTACGGTGCT) to a
ﬁnal concentration of 2 mM, 2 mM and 400 nM respectively. The reactions were
quenched after 40 min by placing the tubes on ice and adding quenching buffer to a
ﬁnal concentration of 0.5% (w/v) SDS, 10 mM EDTA, 10% (v/v) glycerol and
0.005% (w/v) xylene cyanol. The sample were analyzed by electrophoresis on a 15%
acrylamide–Tris base, boric acid, EDTA (TBE) gel. The ﬂuorescence was imaged
using a Typhoon FLA 7000. The oligonucleotides used in the assay were obtained
from Ella Biotech GmBH.
NMR spectroscopy. NMR measurements of MTR4-KOW were performed in
phosphate buffered saline (10 mM PO43−, 137 mM NaCl, 2.7 mM KCl) mixed with
10% (v/v) D2O. Backbone chemical shift assignments of the KOW region were
obtained from two 13C, 15N-labelled samples with protein concentration of 700 μM
and 500 μM, respectively. HNCA, HNCACB, HNcoCA, HNCO, HNcaCO, and 3D
15N-edited NOESY spectra46 were acquired at 298 K on Bruker Avance III spec-
trometers at ﬁeld strengths corresponding to 600 and 800 proton Larmor fre-
quency, equipped with TCI cryogenic probe heads. The 15N steady-state
heteronuclear {1H}-15N NOE experiment was performed at 170 μM and a ﬁeld
strength of 500MHz as described previously47. Protein binding was measured from
HSQC experiments containing water-ﬂip-back/WATERGATE48,49 sequences.
Titrations with the NVL peptide were carried out at 298 K with a KOW con-
centration of 53 μM and in presence of 0.25, 0.5, 1, 2, and 6 stoichiometric molar
equivalents of NVL. Spectra were recorded and processed with Topspin3.5 and
analyzed with CCPNMR Analysis 2.450 and Sparky (http://www.cgl.ucsf.edu/
home/sparky). The chemical shift perturbations were calculated as CSP (ppm)= [6
(ΔH)2+ (ΔN)2]0.5.
Crystallization and structure determination. MTR4ΔN2 (70–1042) was mixed
with 2 molar excess of NVL (167–216) in a buffer containing 20 mM Tris pH 7.5,
150 mM Nacl, 1 mM Mgcl2, 2 mM ADP and 1 mM TCEP. The crystallization trials
were performed using a vapour diffusion setup. Initial crystals were obtained in the
A4 (2 M ammonium sulfate, 0.1 M Tris pH 8.5) condition of SG1TM screen
(Molecular dimensions). The best diffracting crystals were obtained at a con-
centration of 10 mg/ml at 277 K in 0.1 M Tris pH 8, 1.8 M ammonium sulfate. The
crystals were cryo-protected with reservoir solution supplemented with 30% gly-
cerol prior ﬂash-freezing in liquid nitrogen. Data were collected at 100 K at PXIII
beamline of the Swiss light Source (Villigen, Switzerland). Data processing and
scaling was performed using Xia2/DIALS51,52 within CCP4i2 software suite53. The
crystals belong to the hexagonal spacegroup 169 (P61) containing one molecule
(MTR4ΔN2 – NVL167–216) in the asymmetric unit and diffract to 3.07 Å resolution.
The structure was solved by molecular replacement with Phaser54 within Phenix
using the co-ordinates of the DExH core (98-593 and 847–1042) and KOW
domain (645–787) of MTR4 (PDB 6IEH)31 as search models. The model was
manually completed in COOT55 and reﬁned using phenix.reﬁne56. The optimal
TLS groups for TLS reﬁnement were determined using TLSMD server57. 96.1% of
the protein backbone dihedral angles in the ﬁnal model are in Ramachandran
favored region. The ﬁgures of crystallographic models were prepared using pyMOL
(Schrödinger, LLC).
Cell culture and co-immunoprecipitation assays. Human HeLa Kyoto LAP,
MTR4-LAP, RBM7-LAP cell lines were generated as outlined by Poser et al.58 and
used for example by Lubas et al.27 (RBM7-LAP) and Meola et al.30 (MTR4-LAP).
Brieﬂy, HeLa Kyoto LAP MTR4-LAP, RBM7-LAP cells were cultured in DMEM+
10% FBS. Transfection was carried out using 10 µg of plasmid containing FLAG-
tagged NVL or ZCCHC8 constructs, with Lipofectamine 2000 (Thermo Fisher)
following the manufacturer’s instructions. Forty-eight hours after transfection the
cells were collected and resuspended in extraction buffer (150 mM NaCl, 20 mM
HEPES pH 7.4, 0.5% (v/v) Triton X-100) containing Protease Inhibitors (Roche).
The lysates were sonicated twice for 5 s at 20W, and cell debris was removed by
centrifugation at 10,000 g for 10 min. Lysates were incubated 1 h with Dynabeads
M-270 Epoxy (Invitrogen) coupled to a polyclonal llama anti-GFP antibody. Beads
were washed three times in extraction buffer, then incubated 20 min at 25 °C with
100 units of Benzonase (Sigma) and 2 mMMgCl2. Beads were then washed twice in
extraction buffer and proteins were eluted using NuPage LDS Sample Buffer
(Invitrogen) at 70 °C for 10 min, and NuPage Sample Reducing Agent was added.
The input material (0.5%) and the eluate (8.0%) were analyzed by SDS-PAGE on a
NuPage Novex 4–12% Bis-Tris gel (Invitrogen). Western blotting analysis was
performed following standard protocols. Following primary antibodies were used:
anti-FLAG M2 (Dilution 1:50000; Sigma, F1804), anti-MTR4 (Dilution 1:4000;
Abcam, ab70551), anti-GFP (Dilution 1:1000; Santa Cruz Biotechnology, SC-9996),
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anti-β-actin (Dilution 1:100000; Sigma, A2228) and anti-RBM7 (Dilution 1:1000;
human protein atlas, HPA013993). Anti-mouse and anti-rabbit secondary anti-
bodies coupled to Horseradish Peroxidase (Dako) were used.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
A reporting summary for this Article is available as a Supplementary Information ﬁle.
NMR backbone chemical shifts of the human MTR4 KOW domain were deposited at the
BMRB under accession number 27831. The coordinates and the structure factors have
been deposited in the Protein Data Bank with accession code PDB ID 6RO1. The source
data are provided in Supplementary Fig. 10. All data is available from the corresponding
author upon reasonable request.
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